Masimo Corporation is a medical devices business based in the US. Masimo Corporation shares (MASI) are listed on the NASDAQ and all prices are listed in US Dollars. Masimo Corporation employs 3,800 staff and has a trailing 12-month revenue of around $2 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $109.78 |
|---|---|
| 52-week range | $75.22 - $153.93 |
| 50-day moving average | $122.26 |
| 200-day moving average | $117.54 |
| Wall St. target price | $155.72 |
| PE ratio | 72.6259 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $1.47 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $109.78 from 2024-07-25
| 1 week (2024-07-19) | 2.83% |
|---|---|
| 1 month (2024-06-27) | -16.52% |
| 3 months (2024-04-26) | -19.36% |
| 6 months (2024-01-26) | -13.75% |
| 1 year (2023-07-27) | -6.57% |
|---|---|
| 2 years (2022-07-27) | -23.02% |
| 3 years (2021-07-27) | 268.8 |
| 5 years (2019-07-26) | 159.87 |
Valuing Masimo Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Masimo Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Masimo Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 73x. In other words, Masimo Corporation shares trade at around 73x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Masimo Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.7295. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Masimo Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Masimo Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $216.5 million.
The EBITDA is a measure of a Masimo Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2 billion |
|---|---|
| Operating margin TTM | 6.9% |
| Gross profit TTM | $1.1 billion |
| Return on assets TTM | 2.94% |
| Return on equity TTM | 5.87% |
| Profit margin | 4% |
| Book value | $25.72 |
| Market Capitalization | $5.7 billion |
TTM: trailing 12 months
We're not expecting Masimo Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Masimo Corporation's shares have ranged in value from as little as $75.22 up to $153.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Masimo Corporation's is 0.971. This would suggest that Masimo Corporation's shares are less volatile than average (for this exchange).
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth. com, amazon. com, and shopify. com.
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.